Mr BSG

Mannkind: Overlooked Biotech With Excellent Prospects (Part V)

Now that was a well written, logical article. Thanks.

No pie in the sky stuff, like the SP will move 5x's todays price, etc ,etc.



" It all boils down to one question, one valuation. Will Technosphere Insulin succeed? If yes, then the stock is crazy cheap. If no, there is no reason in the world to buy it and it probably isn’t worth the paper that it’s printed on"

Actually the stock isn't cheap. It's sitting with a MC of around $300 Mil, with approval of their only product - T1 - years away.

Good luck